Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jun 1;135(6):617-623.
doi: 10.1001/jamaophthalmol.2017.1082.

β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study

Affiliations
Multicenter Study

β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study

C Gustavo De Moraes et al. JAMA Ophthalmol. .

Abstract

Importance: β-zone parapapillary atrophy (βPPA) has been reported as a risk factor for glaucoma onset and progression. Previous studies have shown that the prevalence of βPPA differs between individuals of African descent (AD) and European descent (ED).

Objective: To test whether the association between the presence and progression of βPPA vs visual field progression of glaucoma differs between these 2 ancestry groups.

Design, setting, and participants: In a prospective, multicenter, longitudinal cohort study, 634 individuals (1090 eyes) enrolled in the African Descent and Evaluation Study (ADAGES) with a diagnosis of glaucomatous optic neuropathy (GON) or ocular hypertension (OHT) and at least 2 disc stereophotographs were included. Two graders masked to clinical and ancestry data reviewed and graded the baseline and last disc stereophotographs for the presence of βPPA at baseline and βPPA progression (development or enlargement). Mixed-effects linear models were tested with visual field mean deviation as a dependent variable and time (alone and with interaction terms) as independent variables. ADAGES enrollment began in January 2003 and ended in July 2006; follow-up ended in 2016.

Exposures: Disc stereophotographs.

Main outcomes and measures: Progression of βPPA in AD and ED individuals.

Results: In 634 patients, a total of 814 eyes of AD (395 eyes) and ED (419) patients with GON and 276 eyes of AD (106) and ED (170) patients with OHT who were enrolled in ADAGES were analyzed. There were 336 (53.0%) women in the study; mean (SD) age was 61.9 (12.7) years. In the OHT group, the association between βPPA at baseline and visual field progression was not significantly different between AD and ED eyes (β = 0.071; 95% CI, -0.016 to 0.158; P = .11), nor was the association between βPPA progression and visual field progression (β = 0.020; 95% CI, -0.465 to 0.506; P = .93). In the GON group, ED eyes with baseline βPPA progressed faster than did AD eyes with baseline βPPA (β = -0.124; 95% CI, -0.241 to -0.007; P = .04), although the association between βPPA progression and visual field progression did not differ significantly between race groups (β = -0.101; 95% CI, -0.323 to 0.119; P = .37).

Conclusions and relevance: Race had a significant effect on the association between baseline βPPA and rates of visual field progression in eyes with GON. Progression of βPPA was not associated with faster visual field progression in either racial group.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Girkin has received research support from Heidelberg Engineering GmbH, Optove Inc, Merck Inc, Topcon Medical Systems Inc, and Carl Zeiss Meditec Inc. Dr Medeiros has received financial support from Alcon Laboratories Inc, Carl Zeiss Meditec Inc, Pfizer Inc; served as a paid consultant for Alcon Laboratories Inc, Allergan Inc, and Pfizer Inc (not directly relevant to the present study); and received research support from Alcon Laboratories Inc, Allergan Inc, Carl Zeiss Meditec Inc, Pfizer Inc, and Reicherts Inc. Dr Weinreb has received financial support from Carl Zeiss Meditec Inc, Heidelberg Engineering GmbH, Optovue Inc, Topcon Medical Systems Inc, and Nidek Inc; served as a paid consultant for Alcon Laboratories Inc, Allergan Inc, Bausch & Lomb, Aerie, Carl Zeiss Meditec Inc, and Optovue Inc; and received grants from Quark and Genentech. Dr Zangwill has received grants and royalties for intellectual property licensed by the University of California, San Diego; financial support from Carl Zeiss Meditec Inc, Heidelberg Engineering GmbH, Optovue Inc, and Topcon Medical Systems Inc, and research support from Heidelberg Engineering GmbH. Dr Liebmann has served as a paid consultant for Alcon Laboratories Inc, Allergan Inc, and Carl Zeiss Meditec Inc and as a consultant for Dyopsis Inc and Topcon Medical Systems Inc. No other disclosures were reported.

Figures

Figure.
Figure.. Example of β-Zone Parapapillary Atrophy (βPPA) Progression Accompanied by Visual Field Changes
A, Baseline disc stereophotograph. B, Follow-up disc stereophotograph (after 6 years) demonstrating βPPA progression. In addition, there was substantial neuroretinal rim thinning during the same period. Note that the βPPA location correlated spatially with the longest distance to the central retinal vessel trunk in the lamina cribrosa, as well as the most marked loss of rim in the disc. C, Baseline corresponding 24-2 Swedish Interactive Thresholding Algorithm standard automated perimetry visual fields of this patient. D, Follow-up visual fields (after 6 years). Note the progression of a superior arcuate defect.

Similar articles

Cited by

References

    1. Prum BE Jr, Rosenberg LF, Gedde SJ, et al. . Primary open-angle glaucoma preferred practice pattern guidelines. Ophthalmology. 2016;123(1):P41-P111. - PubMed
    1. Jonas JB, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes—II: correlations. Invest Ophthalmol Vis Sci. 1989;30(5):919-926. - PubMed
    1. Dai Y, Jonas JB, Huang H, Wang M, Sun X. Microstructure of parapapillary atrophy: beta zone and gamma zone. Invest Ophthalmol Vis Sci. 2013;54(3):2013-2018. - PubMed
    1. Sommer A, Tielsch JM, Katz J, et al. . Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325(20):1412-1417. - PubMed
    1. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma; the Baltimore Eye Survey. JAMA. 1991;266(3):369-374. - PubMed

MeSH terms